SIGN IN YOUR ACCOUNT TO HAVE ACCESS TO DIFFERENT FEATURES
Remember Me
FORGOT YOUR PASSWORD?
FORGOT YOUR DETAILS?
AAH, WAIT, I REMEMBER NOW!
LOGIN
Menu
Home
About
About CEND
History & Mission
Contact
Video Library
People
Leadership
Faculty
Fellows
Programs
CEND Initiatives
Immunotherapeutics and Vaccine Research Initiative (IVRI)
Alliance for Global Health & Science
About the Alliance
Alliance Partners
Alliance Workshops
Alliance Opportunities
UC Berkeley MHIRT
About MHIRT
Research Opportunities
Training Info
Apply
Faculty Travel Awards
MHIRT Student Blog
Contact MHIRT
Global Health Diagnostics (GHDx)
Symposia & Seminars
CEND Annual Symposium
BayViro Symposium
Fellowships
Bay Area Virus Network
About the Network
FAQ
Affiliated Labs
Featured Projects
Resources
Current COVID-19 Funding Opportunities
COVID-19 Lab Facilities, Projects, and Resources
News & Events
BayViro Symposium
Opportunities
Graduate Programs
Jobs
Fellowships
Stories of Success
COVID Catalyst Funding
About the Catalyst Fund
PREP@UC Berkeley
About PREP@UC Berkeley
PREP@UC Berkeley Program
Eligibility
How to apply
Leadership
PREP FACULTY
UC Berkeley Drug Discovery Center
About the UC Berkeley Drug Discovery Center
Our Compound Library
Publications
Our Partners
How do I do a screen?
Drug Discovery MakerSpace
News
Clifton Barry, National Institutes of Health
Dirty by design: Rational Approach to Development of Antitubercular Nitroimidazoles
Tweet
TOP
UA-36873340-1
